IP Library Granted Patent US 8,115,016
Granted Patent B2
US 8,115,016 · App. 12/522,767 · Granted Feb 14, 2012

Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,115,016
App. No.
12/522,767
Granted
Feb 14, 2012
Kind
B2
Abstract

The present invention relates to pyrrolidin-2-ones according to the formula (1), or salts thereof, wherein R1 is hydrogen or a nitrogen protecting group, methods for their preparation and their use in the preparation of NEP-inhibitors, particularly in the preparation of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester or salt thereof.

Claims (52)

1. A compound according to formula (1), or tautomer, or salt thereof,

wherein R1 is hydrogen or a nitrogen protecting group.

2. A compound according to claim 1 , or tautomer, or salt thereof, characterized in that the configuration is according to formula (1-a)

wherein R1 is hydrogen or a nitrogen protecting group.

3. A compound according to claim 1 , wherein R1 is hydrogen.

4. A compound according to claim 1 , wherein R1 is a nitrogen protecting group selected from pivaloyl, pyrrolidinylmethyl, t-butoxycarbonyl, benzyl, silyl, acetyl, benzyloxycarbonyl (Cbz) and trimethylsilyethoxymethyl (SEM).

5. A compound according to claim 1 , characterized in that the compound is the enol-tautomer according to formula (1′)

wherein R1 is hydrogen or a nitrogen protecting group and R1 ′ is hydrogen.

6. A compound according to formula (1′), or salt thereof

wherein R1 is hydrogen or a nitrogen protecting group and R1 ′ is hydrogen or an oxygen protecting group.

7. A compound according to claim 6 having a structure as shown in formula (1″)

wherein R7, R8and R9 are independently, of each other, aryl or alkyl.

8. A process for producing a compound according to formula (2), or tautomer, or salt thereof,

wherein R1 is hydrogen or a nitrogen protecting group, comprising methylating a compound according to formula (1), or tautomer, or salt thereof,

wherein R1 is hydrogen or a nitrogen protecting group.

9. A process according to claim 8 , comprising: treating the compound of formula (1), or tautomer thereof, or salt thereof, with a base and a methylating reagent.

10. A process comprising:

(a) treating a compound of formula (1), or tautomer, or salt thereof,

wherein R1 is hydrogen or a nitrogen protecting group, first with a base and then with a compound of the formula YCO 2 R, wherein Y is halogen or —OR′ and wherein R and R′ are independently selected from alkyl, aryl and arylalkyl, to obtain a compound of formula (20), or salt thereof,

wherein R1 is hydrogen or a nitrogen protecting group, R11 is hydrogen and R10 is OR wherein R is alkyl, aryl or arylalkyl;

b) reacting the resulting compound of formula (20) with a base and a methylating reagent to obtain a compound of formula (20), or salt thereof, wherein R1 is hydrogen or a nitrogen protecting group, R11 is methyl and R10 is OR wherein R is alkyl, aryl or arylalkyl;

c) optionally, treating the compound of formula (20) wherein R1 is hydrogen or a nitrogen protecting group, R11 is methyl and R10 is OR wherein R is alkyl, aryl or arylalkyl, with a saponification reagent, to obtain a compound of formula (20), or salt thereof, wherein R1 is hydrogen or a nitrogen protecting group, R11 is methyl and R10 is OH;

d) treating the compound obtained in step (b) or (c) under decarboxylation conditions to obtain the compound of formula (2) or tautomer, or salt thereof,

11. A process according to claim 10 , characterized in that the configuration of the compound of formula (20) is according to formula (20-a)

12. A process comprising:

(a) treating a compound of formula (1-a), or tautomer, or salt thereof,

wherein R1 is hydrogen or a nitrogen protecting group first with a base and then with a compound of the formula YCO 2 , wherein Y is halogen or —OR′ and wherein R and R′ are independently selected from alkyl, aryl and arylalkyl, to obtain a compound of formula (20-a), or salt thereof,

b) reacting the resulting compound of formula (20-a) with a base and a methylating reagent to obtain a compound of formula (20-a), or salt thereof, wherein R1 is hydrogen or a nitrogen protecting group, R11 is methyl and R10 is OR wherein R is alkyl, aryl or arylalkyl;

c) optionally, treating the compound of formula (20-a) wherein R1 is hydrogen or a nitrogen protecting group, R11 is methyl and R10 is OR wherein R is alkyl, aryl or arylalkyl, with a saponification reagent, to obtain a compound of formula (20-a), or salt thereof, wherein R1 is hydrogen or a nitrogen protecting group, R11 is methyl and R10 is OH;

d) treating the compound obtained in step (b) or (c) under decarboxylation conditions to obtain the compound of formula (2-a), or tautomer, or salt thereof,

wherein R1 is hydrogen or a nitrogen protecting group.

13. A process according to claim 12 , wherein a compound according to formula (1-a), or tautomer, or salt thereof, is used as starting material and a compound according to formula (2-a), or tautomer, or salt thereof, is produced in a diastereomeric ratio of more than 60:40.

14. A process according to claim 9 , wherein the compound according to formula (1), or tautomer, or salt thereof, is characterized by having the configuration according to formula (1-a) and wherein the compound according to formula (2) is produced in a ratio of diasteromers (2-a) to (2-b)

of at least 80:20.

15. A process comprising:

(a) treating a compound of formula (1-a), or tautomer, or salt thereof,

wherein R1 is hydrogen or a nitrogen protecting group, first with a base and then with a compound of the formula YCO 2 R, wherein Y is halogen or —OR′ and wherein R and R′ are independently selected from alkyl, aryl and arylalkyl, to obtain a compound of formula (20-a), or salt thereof,

wherein R1 is hydrogen or a nitrogen protecting group, R11 is hydrogen and R10 is OR wherein R is alkyl, aryl or arylalkyl;

b) reacting the resulting compound of formula (20-a) with a base and a methylating reagent to obtain a compound of formula (20-a), or salt thereof, wherein R1 is hydrogen or a nitrogen protecting group, R11 is methyl and R10 is OR wherein R is alkyl, aryl or arylalkyl;

c) optionally, treating the compound of formula (20-a) wherein R1 is hydrogen or a nitrogen protecting group, R11 is methyl and R10 is OR wherein R is alkyl, aryl or arylalkyl, with a saponification reagent, to obtain a compound of formula (20-a), or salt thereof, wherein R1 is hydrogen or a nitrogen protecting group, R11 is methyl and R10 is OH;

d) treating the compound obtained in step (b) or (c) under decarboxylation conditions to obtain the compound of formula (2) or tautomer, or salt thereof,

wherein the compound according to formula (2) is produced in a ratio of diasteromers (2-a)to (2-b)

of at least 55:45.

16. A process comprising:

(a) treating a compound of formula (1-a), or tautomer, or salt thereof,

wherein R1 is hydrogen or a nitrogen protecting group, first with a base and then with a compound of the formula YCO 2 R, wherein Y is halogen or —OR′ and wherein R and R′ are independently selected from alkyl, aryl and arylalkyl, to obtain a compound of formula (20-a), or salt thereof,

wherein R1 is hydrogen or a nitrogen protecting group, R11 is hydrogen and R10 is OR wherein R is alkyl, aryl or arylalkyl;

b) reacting the resulting compound of formula (20-a) with a base and a methylating reagent to obtain a compound of formula (20-a), or salt thereof, wherein R1 is hydrogen or a nitrogen protecting group, R11 is methyl and R10 is OR wherein R is alkyl, aryl or arylalkyl;

c) optionally, treating the compound of formula (20-a) wherein R1 is hydrogen or a nitrogen protecting group, R11 is methyl and R10 is OR wherein R is alkyl, aryl or arylalkyl, with a saponification reagent, to obtain a compound of formula (20-a), or salt thereof, wherein R1 is hydrogen or a nitrogen protecting group, R11 is methyl and R10 is OH:

d) treating the compound obtained in step (b) or (c) under decarboxylation conditions to obtain the compound of formula (2) or tautomer, or salt thereof,

wherein the compound according to formula (2) is produced in a ratio of diasteromers (2-a)to (2-b)

 of at least 29:79.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2011
From: NOVARTIS AG
To: NOVARTIS PHARMACEUTICALS CORPORATION
Reel/Frame 026002/0790 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2010
From: HOOK, DAVID; RUCH, THOMAS; RISS, BERNHARD; WIETFELD, BERNHARD; SEDELMEIER, GOTTFRIED; NAPP, MATTHIAS; BAENZIGER, MARKUS; HAWKER, STEVEN; CISZEWSKI, LECH; WAYKOLE, LILADHAR MURLIDHAR
To: NOVARTIS AG
Reel/Frame 025036/0223 →